A lot can happen in 10 years. For Alex Keuroghlian, MD, MPH (any pronoun), the last decade has certainly been a busy, productive and significant one, not only ...

The above is the title of a useful manual of Kenney and Keast (2024). Below I summarize some key points. Provide an overview of pharmacy contracts ...

See my previous posts on negotiating IRA prices in drug selection (Part 1) and sending manufacturer data (Part 2). Today we will talk about the ...

CMS launched Guidance on Negotiating IRA Prices last week. Below are some highlights on how medications will be selected. What medications are eligible ...

To account for differences in disease burden among the patient population of Medicare Advantage (MA) plans, risk adjustment based on the patient's disease ...

Today, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) published a new webpage to share answers to frequently ...

Medical debt in the United States is a major problem. While more than 90% of people have health insurance, many people ...

In July 2018, the FDA published the Biosimilars Action Plan (BAP), which outlined the FDA's approach to expanding access ...

Progression-free survival (PFS) is a surrogate endpoint defined as follows (by ChatGPT): Essentially, PFS refers to the period of time during a ...

For patients with serious illnesses, timely access to effective medications is paramount. The European Medicines Agency (EMA) was created in part to help ...